- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Eltrombopag is an oral thrombopoietin receptor agonist primarily used to treat specific types of thrombocytopenia, including chronic liver di...
Eltrombopag is an oral thrombopoietin receptor agonist primarily used to treat chronic liver disease-related thrombocytopenia and chronic immun...
Eltrombopag, as a thrombopoietin receptor agonist, is suitable for the treatment of chronic liver disease-related thrombocytopenia and chronic ...
The correct use of eltrombopag requires strict adherence to indications and individualized dosage requirements. Key points include co administr...
Doptelet, as a thrombopoietin receptor (TPO-R) agonist, has significant therapeutic effects on specific patients with thrombocytopenia. Its effic...
The dosage of Doptelet should be adjusted according to the indications, patient age, and individualized platelet count, including both tablet a...
The use of Doptelet should be implemented according to indications, dosage forms, and patient age differentiation. It should strictly follow co...
The daily dosage of Doptelet should be dynamically adjusted according to indications, platelet count, and patient age. The maximum daily dose f...
Osimertinib is a third-generation EGFR-TKI targeted drug that selectively inhibits EGFR mutations (including T790M) to block tumor signaling pa...
Osimertinib is a third-generation EGFR-TKI targeted drug mainly used for the treatment of EGFR mutation positive non-small cell lung cancer (NS...
